Category: General
Cholesterol Guidelines: Is a blood test necessary starting at age 40?
The modern view of cholesterol is shifting from focusing solely on LDL to a more comprehensive risk assessment. ApoB indicates how many harmful lipoprotein particles are present, while Lp(a) is a genetic risk factor that you should have measured at least once. Starting at age 40, a comprehensive lipid profile can help you better assess your cardiovascular risk.
Your primary care physician might still look at an LDL level below 3.0 mmol/L and conclude that everything is fine. But what if that single measurement actually tells only part of the story about your risk of a heart attack? In 2025, the international guidelines for cardiovascular risk management were radically revised, and this affects everyone over 40.
Why the medical community has revised its approach to cholesterol for 2025
For decades, LDL cholesterol has been central to assessing heart disease risk. The rule of thumb was that lower LDL means lower risk. But this approach has a fundamental flaw: LDL measures the concentration of cholesterol in the blood, not the number of particles that actually cause damage to your artery walls.
As a result, two people with exactly the same LDL level may still have very different cardiovascular risks. Someone with many small, dense LDL particles is at significantly higher risk than someone with few large particles, even if their LDL levels are identical.
The revised 2025 international guidelines explicitly acknowledge this. They shift the focus from treatment to prevention and introduce new measurement standards that provide a more accurate picture of what’s happening in your arteries. This isn’t just a minor adjustment; it changes the way doctors predict and prevent heart disease at its core.
Why your primary care physician might still be using the old values: guidelines take time to trickle down into daily practice. It can take one to three years for new international protocols to be fully implemented in primary care practices. Therefore, be sure to actively request a comprehensive lipid panel when you turn 40 or if you have risk factors.
The 40-Year Milestone: Why Preventive Screening Is Essential Now
The new guidelines explicitly set age 40 as the starting point for preventive lipid screening in adults without known cardiovascular disease. This may sound early, but the rationale is strong.
Atherosclerosis, the buildup of plaque in your arteries, is a process that takes decades. The damage that causes a heart attack when you’re 60 often began to develop around the time you were 35 to 40. By the time you start experiencing symptoms, the disease is usually already well advanced. Early testing makes early intervention possible.
Furthermore, many people’s lipid profiles change significantly between the ages of 40 and 50. Women experience hormonal shifts around menopause, while men often see their LDL levels rise steadily. By taking a baseline measurement at age 40, you’ll have a personal reference point against which future measurements can be compared.
The Importance of Non-Fasting Lipid Panels for Adults
For a long time, the standard was to fast for 12 hours before a cholesterol test. The new guidelines state that for most adults, a non-fasting lipid panel is sufficient and even more practical.
Non-fasting measurements better reflect your body’s daily metabolic state. Non-fasting values are well-suited for calculating cardiovascular risk using models such as SCORE2. Fasting measurements are only necessary in cases of significantly elevated triglycerides or specific diagnostic questions.
Looking Beyond LDL: The Rise of ApoB and Lipoprotein(a)
This is the most significant change in the new guidelines: LDL cholesterol is no longer the only measure that matters.
ApoB: the better indicator
Apolipoprotein B (ApoB) is a protein found on every atherogenic lipoprotein particle, including LDL, VLDL, and IDL. There is always one ApoB molecule per particle. This makes ApoB the most direct measure of the number of artery-narrowing particles in your blood. At Bloedwaardentest.nl, you can have ApoB measured along with Lp(a) in a single test.
| Measurement | What it measures | Limitation |
|---|---|---|
| LDL cholesterol | Amount of cholesterol in LDL | Says nothing about the particle count |
| ApoB | Number of atherogenic lipoprotein particles | Not routinely included in basic screening |
| Non-HDL cholesterol | All “bad” cholesterol combined | Better than LDL, but doesn’t provide a particle count |
ApoB target level: less than 65 mg/dL for high-risk patients, less than 80 mg/dL for moderate-risk patients.
Lipoprotein(a): The Forgotten Risk Factor
Lp(a) is a variant of LDL with an extra protein attached to it. It is strongly genetically determined; your Lp(a) level is hardly affected by lifestyle or medication. An estimated 20% of the population has a genetically elevated Lp(a) level—above 70 mg/dL—without even knowing it. Be sure to read our explanation of exactly what lipoprotein(a) is and why it often goes unnoticed.
The new guidelines recommend measuring Lp(a) at least once in your lifetime. If the level is elevated, this warrants more intensive screening and more aggressive prevention of other risk factors.
Tip: Ask your doctor specifically for an Lp(a) test. This is not included as part of a standard cholesterol test.
How do you interpret the SCORE2 risk table for your age?
SCORE2 is the European model for estimating the 10-year risk of a fatal or non-fatal cardiovascular event. It combines age, sex, smoking status, blood pressure, and lipid profile.
| Risk Category | 10-Year Risk (under 70 years of age) | Recommended Approach |
|---|---|---|
| Low | Below 5% | Lifestyle advice, monitoring |
| Moderate | 5 to 10% | Intensive lifestyle intervention |
| High | 10 to 15% | Consider medication in addition to lifestyle changes |
| Very high | Above 15% | Strongly Consider Medication |
Cholesterol by age table: LDL and ApoB target levels by risk group (2025)
These target values are the guidelines that doctors use when evaluating a lipid profile. The target value that applies to you depends on your overall risk profile. Therefore, always discuss your results with a doctor or specialist.
| At-risk group | LDL target level | ApoB target level |
|---|---|---|
| Low risk | Below 3.0 mmol/L | Below 100 mg/dL |
| Moderate risk | Below 2.6 mmol/L | Below 80 mg/dL |
| High risk | Below 1.8 mmol/L | Below 65 mg/dL |
| Very high risk | Below 1.4 mmol/L | Below 55 mg/dL |
| Extremely high risk* | Below 1.0 mmol/L | Below 45 mg/dL |
* An extremely high risk applies in cases of a recurrent cardiovascular event despite maximum therapy.
Risk Factors: Diabetes and Chronic Kidney Disease
Type 2 diabetes: People with diabetes are routinely classified into the high- or very high-risk category, depending on the duration of the disease and any organ damage. This means lower LDL target levels and, often, an earlier start to discussions about medication.
Chronic kidney disease: An eGFR below 60 mL/min or significant proteinuria indicates an increased risk, even in the absence of other classic risk factors. The SCORE2 model has separate modules—SCORE2-Diabetes and SCORE2-CKD—for these groups.
Action Plan: When Should You Start Lifestyle Intervention?
The new guidelines are clear: lifestyle changes always take precedence over medication, except in cases of very high risk, where both are used simultaneously.
Start lifestyle intervention immediately if:
- Your SCORE2 risk is moderate or higher
- Your LDL is above the target level for your risk group
- If your ApoB is above 100 mg/dL,
- If your Lp(a) is above 70 mg/dL,
Four factors make the biggest difference here:
- Diet: Replacing saturated fats with unsaturated fats significantly lowers LDL. The Mediterranean diet and plant-based proteins are evidence-based choices.
- Exercise: 150 to 300 minutes of moderate-intensity exercise per week improves the lipid profile, primarily by increasing HDL and lowering triglycerides.
- Weight: Losing 5 to 10% of your body weight significantly lowers LDL, triglycerides, and ApoB.
- Quitting smoking: Smoking lowers HDL and significantly increases the SCORE2 risk. Quitting is the intervention with the greatest impact.
When should you discuss medication with your doctor? If lifestyle changes haven’t had enough effect after three to six months and your risk profile warrants it, your doctor may consider prescribing a statin or a PCSK9 inhibitor.
The key takeaway: The 2025 cholesterol guidelines are definitively shifting the focus toward early, comprehensive screening. LDL alone is no longer enough. A complete lipid profile, including ApoB and Lp(a), provides a more accurate picture of your actual heart disease risk. Don’t wait until you have symptoms—start at age 40.
Have a question about your results?Leave a comment. Our specialists are happy to help you.
Want immediate results?Check out the recommended tests:
